Vnitr Lek 2009, 55(6):599-603

Venous thromboembolism in an oncology patient

A. Uhrinová*, P. Gavorník, I. Vacula
II. interná klinika Lekárskej fakulty UK a FNsP Bratislava, Slovenská republika, prednosta prof. MUDr. Andrej Dukát, CSc., FESC

Venous thromboembolism is a common complication in many patients with different types of malignant tumors. In this paper we describe a case of a patient with cancer in remission, who developed pulmonary embolism.

Keywords: pulmonary embolism; malignancy

Received: January 16, 2009; Accepted: February 25, 2009; Published: June 1, 2009  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Uhrinová A, Gavorník P, Vacula I. Venous thromboembolism in an oncology patient. Vnitr Lek. 2009;55(6):599-603.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Trousseau A. Phlegmasia alba dolens. Clinique medicinale de l'Hotel Dieu de Paris. Paris: J-B Baillière § Fils 1865: 645-712.
    2. Lee AY. Management of thrombosis in cancer: primary prevention and secondary prophylaxis. Br J Haematol 2005; 128: 291-302. Go to original source... Go to PubMed...
    3. Prandoni P. Acquired risk factors for venous thromboembolism in medical patients. Pathophysiol Haemost Thromb 2006; 35: 128-132. Go to original source... Go to PubMed...
    4. Büller HR, van Doormaal FF, van Sluis GL et al. Cancer and thrombosis: from molecular mechanisms to clinical presentations. J Thromb Haemost 2007; 5 (Suppl 1): 246-254. Go to original source...
    5. Alcalay A, Wun T, Khatri V et al. Venous thromboembolism in patients with colorectal cancer: incidence and effect on survival. J Clin Oncol 2006; 24: 1112-1118. Go to original source... Go to PubMed...
    6. American College of Emergency Physicians Clinical Policies Committee. Clinical policy: critical issues in the evaluation and management of adult patients presenting with suspected pulmonary embolism. Ann Emerg Med 2003; 41: 257-270. Go to original source... Go to PubMed...
    7. Righini M, Perrier A, De Moerloose P et al. D-Dimer for venous thromboembolism diagnosis: 20 years later. J Thromb Haemost 2008; 6: 1059-1071. Go to original source... Go to PubMed...
    8. Lee AY. Venous thromboembolism and cancer: prevention and therapy. Vnitř Lék 2006; 52 (Suppl 1): 127-131. Go to PubMed...
    9. Hirmerová J. Optimální délka antikoagulační léčby po žilní tromboembolické příhodě: obecný či individualizovaný přístup? Vnitř Lék 2007; 53: 662-668. Go to PubMed...
    10. Lee AY, Levine MN, Baker RI et al. Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer. N Engl J Med 2003; 349: 146-153. Go to original source... Go to PubMed...

    Return to the content


    Vnitřní lékařství

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.